# VPsych Excellence Audit (VEA)
## Comprehensive Product Audit — Executive Board Master Certification

| Field | Value |
|---|---|
| Audit ID | VEA-2026-08-05 |
| Date (UTC) | 2026-08-05 |
| Mode | **Observational only** — no product code changes; no score gaming |
| Production URL | https://vpsych.vercel.app |
| Production SHA | `5aae138` (GitHub Production deploy 2026-08-05T17:18:48Z) |
| Package | `0.1.0` |
| Board composition (simulated lenses) | Consultant psychiatry · Clinical psychology · Residency directors · Med ed · AI safety · Security · UX · A11y · Research methods · Enterprise |

### Audit principles applied

Audit production first. Assume nothing. Trust nothing. Verify everything.  
Evidence over assumptions. Do not hide weaknesses. Do not inflate scores.  
Unmerged draft excellence work is **roadmap evidence**, not production capability.

---

## 0. Production verification snapshot

| Probe | Result |
|---|---|
| `GET /api/health` | 200 `{"ok":true,"service":"vpsych"}` |
| Homepage / login / privacy / terms | 200 |
| `/robots.txt`, `/sitemap.xml` | 200 |
| Unauth `/avatars`, `/admin/reports` | 307 → login |
| Unauth `/api/admin/*`, `POST /api/sessions` | 401 JSON |
| Security headers | CSP, HSTS preload, XFO DENY, COOP/CORP, Permissions-Policy |
| Prompt on `origin/main` | **v2 multilingual** (not v4.1 PME/TRE) |
| PME/TRE/HCFI/Quality Ledger on main | **Absent** |
| Draft PRs #120–#124 | Open; **not Production** |
| Landing HTML | Contains `10,000+`, `500+`, `25+`, `95%`, `Trusted by` |
| OG / JSON-LD / llms.txt | Absent |

---

## Final scores

| Index | Score |
|---|---:|
| Clinical Excellence Index (CEI) | **62** |
| Human Conversation Fidelity Index (HCFI) | **48** |
| Educational Excellence Index (EEI) | **74** |
| User Experience Index (UXI) | **70** |
| AI Quality Index (AQI) | **55** |
| Voice Authenticity Index (VAI) | **72** |
| Scientific Excellence Index (SEI) | **35** |
| Security Excellence Index (SSI) | **84** |
| Performance Excellence Index (PEI) | **78** |
| Enterprise Readiness Index (ERI-E) | **48** |
| Digital Presence Index (DPI) | **52** |
| **VPsych Excellence Index (VEI)** | **61** |

**VEI** = `0.15·CEI + 0.15·HCFI + 0.12·EEI + 0.08·UXI + 0.12·AQI + 0.08·VAI + 0.10·SEI + 0.08·SSI + 0.05·PEI + 0.04·ERI-E + 0.03·DPI`

Detail: `Clinical_Audit.md`, `Conversation_Audit.md`, `Educational_Audit.md`, `UX_Audit.md`, `Research_Audit.md`, `Security_Audit.md`, `Performance_Audit.md`, `Enterprise_Audit.md`, `SEO_AEO_Audit.md`.

---

## Executive decision

# ⚠ READY FOR LIMITED EXPERT PREVIEW

**Not** ✅ Professional Beta.  
Downgrade to ❌ if P0 trust/disclosure gates are not closed before invites.

Conditions: see `Executive_Summary.md`.

---

## Section summaries (A–L)

### A — Clinical Excellence (CEI 62)
Strong Case Engine + bilingual personas + W2 clinical fixes on production. PME/TRE **not live**. Violence pedagogy thin. Human authenticity unmeasured.

### B — Human Conversation (HCFI 48)
Prompt-v2 dialogue useful for training; **psychiatrists forgetting AI is unproven** (PAS n=0). HCTF stack draft-only.

### C — Educational Quality (EEI 74)
Best production pillar: ACE, CGE, templates, presets, admin reports. Assessment validity is the ceiling.

### D — UX (UXI 70)
Coherent bilingual app shell; accessibility thin; landing trust defect.

### E — AI Quality (AQI 55)
Operational generative patient; hallucination/injection residual; no PME ownership on prod; fallback path risk.

### F — Voice (VAI 72)
STT/TTS pipeline production-real; clinical prosody controls limited vs draft HCTF; E2E stream-to-play incomplete; latency SLOs unpublished.

### G — Scientific Quality (SEI 35)
Scientific ledgers/indices largely **not on production**. Publication readiness blocked. Docs/tooling drift on reliability.

### H — Security (SSI 84)
Re-verified headers/auth; prior cert stands with recommendations. Horizontal rate-limit + compliance gaps remain.

### I — Performance (PEI 78)
Warm web/API snappy; no cohort-scale load proof; assessment end-path heavy.

### J — Enterprise (ERI-E 48)
Schema scaffolding ahead of SSO/licensing/hard tenancy.

### K — Discoverability (DPI 52)
robots/sitemap/legal live; OG/AEO absent.

### L — Product Excellence (feeds VEI 61)
Innovative architecture; execution/validation/deploy discipline lag narrative.

---

## 1. Top 25 strengths

1. Native bilingual clinical authorship (en-US / ar-JO), never machine-translated.  
2. Dynamic Clinical Case Engine — persona does not own diagnosis.  
3. Immutable per-session clinical snapshots.  
4. ACE adaptive curriculum on production.  
5. CGE competency graph on production.  
6. Instructor presets + scenario templates with objectives/competencies.  
7. Admin-only session reports (therapist API cannot fetch report body).  
8. HMAC-signed insert-once report write path.  
9. Defense-in-depth AuthZ (middleware + API + RLS).  
10. Live security headers (CSP/HSTS/COOP/CORP).  
11. Client-safe API errors (no raw provider leakage pattern).  
12. Rate limiting on route handlers.  
13. Demo accounts banned.  
14. Password complexity policy.  
15. Safe redirect hardening.  
16. Voice pipeline STT → reply → TTS operational.  
17. Public legal pages + robots/sitemap allowlist live.  
18. Session hard expiry server-enforced (40 min).  
19. Soft-fail ACE/CGE paths (session completes if tables missing).  
20. CI pipeline discipline (lint/typecheck/test/migrations/build).  
21. W2 clinical remediations merged to production (`5aae138`).  
22. Cultural_context fields in personalities.  
23. Risk/safety module in prompt v2.  
24. Health liveness endpoint.  
25. Internal honesty in Mission 22 / CLAUDE that scores are unvalidated — when obeyed.

---

## 2. Top 50 weaknesses

1. PAS human authenticity n=0.  
2. LAS learner authenticity n=0.  
3. Competency scores unvalidated but numeric.  
4. Production prompt still v2 while drafts claim PME/TRE.  
5. PME not deployed.  
6. TRE not deployed.  
7. HCFI engine not deployed.  
8. Quality Ledger not on main/production.  
9. CFI/ERI/AVI/ALE/RRS/VQI admin stack not on main.  
10. Landing false social proof (`10,000+` etc.).  
11. “Trusted by Professionals” unverified.  
12. Missing `ASSESSMENT_RELIABILITY.md` despite CLAUDE.  
13. Missing calibration corpus / reliability harness.  
14. Assessment formula SSOT drift.  
15. Thin disorder packages (AUD/panic/BPD/delirium depth).  
16. Violence assessment pedagogy weak.  
17. Active high-intent SI training envelope narrow.  
18. Medication fidelity uneven.  
19. Differentials missing on some active disorders.  
20. No secondary anti-leakage output filter.  
21. Prompt-injection residual.  
22. Persona-fallback AI-tell risk.  
23. Arabic limited to ar-JO.  
24. No multi-session human longitudinal study.  
25. Therapist feedback loop incomplete (admin-only full report).  
26. Reflection journal product thin.  
27. Accessibility not WCAG-certified.  
28. Sparse aria/axe coverage.  
29. No Open Graph metadata.  
30. No JSON-LD.  
31. No llms.txt / AEO pack.  
32. Enterprise SSO unimplemented.  
33. Licensing absent.  
34. Hard multi-tenant isolation partial.  
35. App roles binary vs enterprise faculty enum.  
36. In-memory rate-limit fallback.  
37. CSP unsafe-inline/eval.  
38. Incomplete admin audit-event coverage.  
39. HIPAA/SOC2 not certified; DSAR UX incomplete.  
40. No cohort-scale load test evidence.  
41. Voice p50/p95 unpublished.  
42. TTS buffered before play.  
43. Scientific dashboards risk looking “green” without humans.  
44. Draft PR sprawl / deployment drift.  
45. Package still `0.1.0`.  
46. Remember-Me historical no-op risk.  
47. global-error lang hardcoded en.  
48. Research export not on production.  
49. Competitive “world-leading” claim unsupported.  
50. Expert preview briefing materials not yet productionized.

---

## 3. Critical findings

| ID | Finding | Root cause | Edu impact | Priority |
|---|---|---|---|---|
| VEA-C1 | Excellence narrative (PME/TRE/scientific indices) ≠ production | Unmerged draft stack #120–#124 | Experts would audit the wrong system | P0 |
| VEA-C2 | Human authenticity evidence empty | PAS/LAS not executed | Blocks realism claims | P0 |
| VEA-C3 | Unvalidated scores presented as assessments | LLM/heuristic examiner without coefficients | Mis-education / research harm | P0 |
| VEA-C4 | Production landing unverified social proof | Hardcoded marketing stats | Trust / ethics defect | P0 |
| VEA-C5 | Reliability docs/tooling referenced but missing | CLAUDE/docs drift | False confidence in audits/CI | P0 |

---

## 4. High findings

| ID | Finding | Priority |
|---|---|---|
| VEA-H1 | Violence / high-risk case under-coverage | P1 |
| VEA-H2 | Uneven disorder package depth | P1 |
| VEA-H3 | HCTF/conversation micro-structure not on prod | P1 |
| VEA-H4 | Horizontal rate-limit weakness if Upstash unset | P1 |
| VEA-H5 | Enterprise SSO/tenancy/licensing gaps | P1 |
| VEA-H6 | No load test at exam-day scale | P1 |
| VEA-H7 | Accessibility program immature | P1 |
| VEA-H8 | Compliance ops (BAA/DSAR/SIEM) incomplete | P1 |
| VEA-H9 | AR dialect generalization risk | P1 |
| VEA-H10 | Structural indices (draft) misreadable as validity | P1 |

---

## 5. Medium findings

CSP nonces absent · prompt-injection residual · TTS buffer latency · incomplete admin audit coverage · instructor role friction · OG/AEO gaps · medication package unevenness · assessment end-path latency · hreflang absent · global-error locale · reflection journal thin.

---

## 6. Low findings

HIBP disabled · ephemeral TTS cache · Remember-Me confusion · marketing anchor leftovers · package version naming.

---

## 7–10. Improvement horizons

See `Product_Roadmap.md` for Quick wins / Short-term / Medium-term / Strategic lists.

---

## 11. Research opportunities

Blinded PAS · PAB arms · TRE gradualism recognition · cross-cultural disclosure · OSCE criterion correlation · voice vs text learning outcomes.

## 12. Commercial opportunities

Supervised residency labs · GP triage modules · Arabic psychiatry education niche · multi-center research network · single-university enterprise pilot.

## 13. Competitive advantages

Bilingual native authorship · Case Engine separation · ACE+CGE depth · security posture · (future) PME/TRE if deployed and validated.

## 14. International expansion readiness

**Low–moderate.** ar-JO + en-US is a wedge, not global coverage. Enterprise SSO/compliance incomplete. Dialect strategy required before MENA-wide claims.

## 15. Recommended next development phase

**Production Parity & Human Measurement Gate** — merge/deploy a coherent authenticity stack **or** silence the narrative; run PAS/LAS; close trust defects; then re-audit.

---

## Voice Authenticity Index (VAI) — Section F detail

| Dimension | Score | Evidence |
|---|---:|---|
| Speech clarity | 75 | ElevenLabs production path |
| Pronunciation | 72 | Locale voice profiles |
| Prosody | 65 | Limited vs draft clinical settings |
| Emotion | 60 | Partial; not PME-coupled on prod |
| Latency | 68 | Interactive historically; SLO unpublished |
| Streaming | 58 | Server stream + client buffer |
| Arabic speech | 70 | Dedicated AR voices/config |
| English speech | 74 | Default EN voices |
| Natural pauses | 60 | Settings-dependent |
| Diagnosis-specific style | 55 | Prompt-level; HCTF disorder speech profiles draft |

**VAI = 72 / 100**

---

## Appendix A — What this audit did *not* do

- Did not modify application code to raise scores.  
- Did not run full authenticated clinical voice sessions as a psychiatrist (no prod credentials for expert role-play in this environment).  
- Did not re-execute penetration tests of already-remediated Criticals.  
- Did not treat draft PR functionality as production.

## Appendix B — Document index

All deliverables under `docs/audit/`:

Executive_Summary · Clinical_Audit · Conversation_Audit · Educational_Audit · UX_Audit · Security_Audit · Performance_Audit · Research_Audit · Enterprise_Audit · SEO_AEO_Audit · Competitive_Analysis · Product_Roadmap · Quality_Dashboard · this master file.

---

*VEA-2026-08-05 — End of master audit*
